- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,503GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,503GBP
The Inhaled Drug Delivery market is composed of two main types of devices: inhalers and nebulisers. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that convert liquid medication into a mist that can be inhaled. Both types of devices are used to treat a variety of respiratory conditions, such as asthma, COPD, and cystic fibrosis.
Inhalers and nebulisers are used to deliver a range of medications, including bronchodilators, corticosteroids, and antibiotics. Inhalers are typically used for short-term relief of symptoms, while nebulisers are used for long-term management of chronic conditions.
Inhaled Drug Delivery is a rapidly growing market, driven by advances in technology and an increasing prevalence of respiratory conditions. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, Novartis, AstraZeneca, and Teva Pharmaceuticals. Show Less Read more